Literature DB >> 15717311

Sequence variation within the 5' regulatory regions of the vitamin D binding protein and receptor genes and prostate cancer risk.

La Creis R Kidd1, Dina N Paltoo, Songping Wang, Weidong Chen, Folasade Akereyeni, William Isaacs, Chiledum Ahaghotu, Rick Kittles.   

Abstract

BACKGROUND: The vitamin D receptor (VDR) and binding protein (DBP) mediate the cellular transport, activity, and anti-tumor action of 1,25-dihydroxyvitamin D3 [1,25-(OH)(2)D3]. The purpose of this investigation is to determine whether novel single nucleotide polymorphisms (SNPs) within the transcriptional regulatory regions of the VDR and DBP are associated with prostate cancer risk.
METHODS: Novel SNPs were identified in the VDR and DBP transcription regulatory gene regions and genotyped in a case-control study using male subjects with (n=258) or without (n=434) prostate cancer.
RESULTS: African-American men who possessed at least one variant VDR-5132 C allele had a increased risk of prostate cancer (OR=1.83; 95% CI: 1.02, 3.31). Further study revealed that the VDR-5132 T/C SNP eliminates a GATA-1 transcription factor-binding site.
CONCLUSION: The VDR-5132 T/C SNP, resulting in potential elimination of the GATA-1 transcription factor-binding site, may increase prostate cancer susceptibility in African-Americans. Confirmation of these findings is needed in larger observational studies. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15717311     DOI: 10.1002/pros.20204

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  13 in total

1.  Vitamin D pathway gene variants and prostate cancer prognosis.

Authors:  Sarah K Holt; Erika M Kwon; Joseph S Koopmeiners; Daniel W Lin; Ziding Feng; Elaine A Ostrander; Ulrike Peters; Janet L Stanford
Journal:  Prostate       Date:  2010-09-15       Impact factor: 4.104

2.  A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations.

Authors:  J B Schwartz; J Lai; B Lizaola; L Kane; S Markova; P Weyland; N A Terrault; N Stotland; D Bikle
Journal:  J Clin Endocrinol Metab       Date:  2014-01-31       Impact factor: 5.958

3.  GC Glu416Asp and Thr420Lys polymorphisms contribute to gastrointestinal cancer susceptibility in a Chinese population.

Authors:  Liqing Zhou; Xiaojiao Zhang; Xuechao Chen; Li Liu; Chao Lu; Xiaohu Tang; Juan Shi; Meng Li; Mo Zhou; Zhouwei Zhang; Lingchen Xiao; Ming Yang
Journal:  Int J Clin Exp Med       Date:  2012-01-15

4.  Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry.

Authors:  Jenny N Poynter; Elizabeth T Jacobs; Jane C Figueiredo; Won H Lee; David V Conti; Peter T Campbell; A Joan Levine; Paul Limburg; Loic Le Marchand; Michelle Cotterchio; Polly A Newcomb; John D Potter; Mark A Jenkins; John L Hopper; David J Duggan; John A Baron; Robert W Haile
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01-19       Impact factor: 4.254

5.  A novel distal enhancer mediates cytokine induction of mouse RANKl gene expression.

Authors:  Kathleen A Bishop; Mark B Meyer; J Wesley Pike
Journal:  Mol Endocrinol       Date:  2009-10-30

6.  Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.

Authors:  Alison M Mondul; Irene M Shui; Kai Yu; Ruth C Travis; Victoria L Stevens; Daniele Campa; Frederick R Schumacher; Regina G Ziegler; H Bas Bueno-de-Mesquita; Sonja Berndt; E D Crawford; Susan M Gapstur; J Michael Gaziano; Edward Giovannucci; Christopher A Haiman; Brian E Henderson; David J Hunter; Mattias Johansson; Timothy J Key; Loïc Le Marchand; Sara Lindström; Marjorie L McCullough; Carmen Navarro; Kim Overvad; Domenico Palli; Mark Purdue; Meir J Stampfer; Stephanie J Weinstein; Walter C Willett; Meredith Yeager; Stephen J Chanock; Dimitrios Trichopoulos; Laurence N Kolonel; Peter Kraft; Demetrius Albanes
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-02-01       Impact factor: 4.254

7.  rs12512631 on the group specific complement (vitamin D-binding protein GC) implicated in melanoma susceptibility.

Authors:  Maria Peña-Chilet; Maider Ibarrola-Villava; Manuel Martin-González; Marta Feito; Cristina Gomez-Fernandez; Dolores Planelles; Gregorio Carretero; Ana Lluch; Eduardo Nagore; Gloria Ribas
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

8.  Vitamin d, sunlight and prostate cancer risk.

Authors:  Krishna Vanaja Donkena; Charles Y F Young
Journal:  Adv Prev Med       Date:  2011-06-08

9.  Genetic variation in vitamin D-related genes and risk of colorectal cancer in African Americans.

Authors:  Fabio Pibiri; Rick A Kittles; Robert S Sandler; Temitope O Keku; Sonia S Kupfer; Rosa M Xicola; Xavier Llor; Nathan A Ellis
Journal:  Cancer Causes Control       Date:  2014-02-23       Impact factor: 2.506

10.  Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk.

Authors:  Sascha Abbas; Alexandra Nieters; Jakob Linseisen; Tracy Slanger; Silke Kropp; Elke Jonny Mutschelknauss; Dieter Flesch-Janys; Jenny Chang-Claude
Journal:  Breast Cancer Res       Date:  2008-04-17       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.